[In vitro activity of Septivon-Lavril toward mycoplasma pathogenic to humans].
Septivon-Lavril is bactericidal in vitro towards species of mycoplasmas responsible for vaginal infections and their complications (U. urealyticum and M. hominis) and for the Stevens-Johnson syndrome (M. pneumoniae). As the active doses are inferior to those recommended for external use, this product, Trichlorocarbanilide, presents a clinical interest.
D000900:Anti-Bacterial Agents / Q000494:pharmacology*; D002224:Carbanilides / Q000494:pharmacology*; D005260:Female; D006801:Humans; D008826:Microbial Sensitivity Tests; D009174:Mycoplasma / Q000187:drug effects* / Q000302:isolation & purification; D014526:Urethritis / Q000382:microbiology; D014627:Vaginitis / Q000382:microbiology
D000900:Anti-Bacterial Agents; D002224:Carbanilides; C009540:triclocarban
Activité in vitro du Septivon-Lavril vis-à-vis des mycoplasmes pathogènes pour l'homme.